Press Releases
Meeting manufacturing demand in the new era of mRNA technologies
Representing a versatile treatment modality for a variety of indications, messenger RNA (mRNA) technologies have
paved the way for a new era of biotherapeutics used for therapeutic protein replacement, gene editing, cell therapy,
vaccines, cancer therapy, and more over the last five years. Recognizing the transformative potential of mRNA-based
medicines, it is even considered as the most suitable modality for the personalized therapeutics, and the biopharma
industry has invested heavily in RNA technologies to support growing demand.
Read more
Representing a versatile treatment modality for a variety of indications, messenger RNA (mRNA) technologies have
paved the way for a new era of biotherapeutics used for therapeutic protein replacement, gene editing, cell therapy,
vaccines, cancer therapy, and more over the last five years. Recognizing the transformative potential of mRNA-based
medicines, it is even considered as the most suitable modality for the personalized therapeutics, and the biopharma
industry has invested heavily in RNA technologies to support growing demand.
Read more